TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Scientists at University of Texas, Health Center release new data on life sciences
September 23rd, 2008
Data detailed in 'Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen' have been presented. According to recent research from the United States, "CD4+ T cells are believed to play a dominant role in human defenses against Mycobacterium tuberculosis through production of interferon (IFN)-gamma, cytolytic T-cell (CTL) activity, and inhibition of intracellular mycobacterial growth. Most functional studies of CD4+ cells have used bulk T-cells that recognize crude mycobacterial antigens, and the functional capacity of individual human T cells is not well defined." "We studied the functional capacity of...
Source: TB & Outbreaks Week (2008-09-23)
|
